COMPARE GENERIKS INC
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: COMPARE GENERIKS INC, 10QSB, 2000-11-14
Next: UNIVERSAL DISPLAY CORP PA, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The schedule contains summary financial information extracted from the financial
statements and is qualified in its entirety by reference to such financial
statement.
</LEGEND>

 <MULTIPLIER>                                  1


<S>                                            <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-END>                                   SEP-30-2000
<CASH>                                         5,572,678
<SECURITIES>                                   0
<RECEIVABLES>                                  1,844,948
<ALLOWANCES>                                   10,000
<INVENTORY>                                    7,877,677
<CURRENT-ASSETS>                               15,696,446
<PP&E>                                         79,482
<DEPRECIATION>                                 42,512
<TOTAL-ASSETS>                                 16,278,144
<CURRENT-LIABILITIES>                          11,718,957
<BONDS>                                        0
                          0
                                    590
<COMMON>                                       491
<OTHER-SE>                                     4,563,106
<TOTAL-LIABILITY-AND-EQUITY>                   16,278,144
<SALES>                                        19,643,941
<TOTAL-REVENUES>                               19,643,941
<CGS>                                          17,656,632
<TOTAL-COSTS>                                  17,656,632
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2,082
<INCOME-PRETAX>                                252,267
<INCOME-TAX>                                   116,000
<INCOME-CONTINUING>                            136,267
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   136,267
<EPS-BASIC>                                    .02
<EPS-DILUTED>                                  .02



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission